{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:04:18Z","timestamp":1790903058139,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oxaliplatin is an anticancer therapy for pancreatic, gastric, and colorectal cancers. It is also used in patients with carcinomas of unknown primary sites. Oxaliplatin is associated with less frequent renal dysfunction than other conventional platinum-based drugs such as cisplatin. Albeit, there have been several reports of acute kidney injury with frequent use. In all cases, renal dysfunction was temporary and did not require maintenance dialysis. There have been no previous reports of irreversible renal dysfunction after a single dose of oxaliplatin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Previous reports of oxaliplatin-induced renal injury occurred after patients received multiples doses. In this study, a 75-year-old male with unknown primary cancer and underlying chronic kidney disease developed acute renal failure after receiving the first dose of oxaliplatin. Suspected of having drug-induced renal failure through an immunological mechanism, the patient was treated with steroids; however, treatment was ineffective. Renal biopsy ruled out interstitial nephritis and revealed acute tubular necrosis. Renal failure was irreversible, and the patient subsequently required maintenance hemodialysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We provide the first report of pathology-confirmed acute tubular necrosis after the first dose of oxaliplatin which led to irreversible renal dysfunction and maintenance dialysis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03116-2","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T12:03:31Z","timestamp":1680005011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biopsy-proven first dose of oxaliplatin-induced acute tubular necrosis leading to end-stage renal failure: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Yu","family":"Soma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiichi","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyu","family":"Kitaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumire","family":"Sunohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Iwano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"3116_CR1","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343\u201351. https:\/\/doi.org\/10.1056\/NEJMoa032709.","journal-title":"N Engl J Med"},{"key":"3116_CR2","first-page":"121","volume":"20","author":"MW Saif","year":"2019","unstructured":"Saif MW, Wasif K, Goodman MD, Hegde S, Sterling M, Yacavone R, et al. Simplified\/same day(s)-GOLF as first-line treatment of metastatic carcinoma of unknown primary (CUP), suggestive of pancreatobiliary tumors. JOP. 2019;20:121\u20134.","journal-title":"JOP"},{"key":"3116_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.bcp.2007.03.004","volume":"74","author":"S Yokoo","year":"2007","unstructured":"Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem Pharmacol. 2007;74:477\u201387. https:\/\/doi.org\/10.1016\/j.bcp.2007.03.004.","journal-title":"Biochem Pharmacol"},{"key":"3116_CR4","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/annonc\/mdf311","volume":"13","author":"G Pinotti","year":"2002","unstructured":"Pinotti G, Martinelli B. A case of acute tubular necrosis due to oxaliplatin. Ann Oncol. 2002;13:1951\u20132. https:\/\/doi.org\/10.1093\/annonc\/mdf311.","journal-title":"Ann Oncol"},{"key":"3116_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/ndtplus\/sfp008","volume":"2","author":"NT Phan","year":"2009","unstructured":"Phan NT, Heng AE, Lautrette A, K\u00e9m\u00e9ny JL, Souweine B. Oxaliplatin-induced acute renal failure presenting clinically as thrombotic microangiopathy: think of acute tubular necrosis. NDT Plus. 2009;2:254\u20136. https:\/\/doi.org\/10.1093\/ndtplus\/sfp008.","journal-title":"NDT Plus"},{"key":"3116_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/ckj\/sft148","volume":"7","author":"N Filewod","year":"2014","unstructured":"Filewod N, Lipman ML. Severe acute tubular necrosis observed subsequent to oxaliplatin administration. Clin Kidney J. 2014;7:68\u201370. https:\/\/doi.org\/10.1093\/ckj\/sft148.","journal-title":"Clin Kidney J"},{"key":"3116_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/ndt\/gfh826","volume":"20","author":"J Labaye","year":"2005","unstructured":"Labaye J, Sarret D, Duvic C, H\u00e9rody M, Didelot F, N\u00e9d\u00e9lec G, et al. Renal toxicity of oxaliplatin. Nephrol Dial Transplant. 2005;20:1275\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfh826.","journal-title":"Nephrol Dial Transplant"},{"key":"3116_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1177\/1060028019865870","volume":"53","author":"M Uchida","year":"2019","unstructured":"Uchida M, Kondo Y, Suzuki S, Hosohata K. Evaluation of acute kidney injury associated with anticancer drugs used in gastric cancer in the japanese adverse drug Event Report Database. Ann Pharmacother. 2019;53:1200\u20136. https:\/\/doi.org\/10.1177\/1060028019865870.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"3116_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000168085","volume":"10","author":"K Joh","year":"1990","unstructured":"Joh K, Aizawa S, Yamaguchi Y, Inomata I, Shibasaki T, Sakai O, et al. Drug-induced hypersensitivity nephritis: lymphocyte stimulation testing and renal biopsy in 10 cases. Am J Nephrol. 1990;10(3):222\u201330. https:\/\/doi.org\/10.1159\/000168085.","journal-title":"Am J Nephrol"},{"key":"3116_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","volume":"59","author":"WJ Pichler","year":"2004","unstructured":"Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59:809\u201320. https:\/\/doi.org\/10.1111\/j.1398-9995.2004.00547.x.","journal-title":"Allergy"},{"key":"3116_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10157-012-0620-8","volume":"16","author":"I Ito","year":"2012","unstructured":"Ito I, Ito Y, Mizuno M, Suzuki Y, Yasuda K, Ozaki T, et al. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin. Clin Exp Nephrol. 2012;16:490\u20134. https:\/\/doi.org\/10.1007\/s10157-012-0620-8.","journal-title":"Clin Exp Nephrol"},{"key":"3116_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s13730-019-00390-8","volume":"8","author":"S Yamada","year":"2019","unstructured":"Yamada S, Yazawa M, Yamamoto M, Koitabashi K, Ichikawa D, Koike J, et al. A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia. CEN Case Rep. 2019;8:188\u201393. https:\/\/doi.org\/10.1007\/s13730-019-00390-8.","journal-title":"CEN Case Rep"},{"key":"3116_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/1060028014526160","volume":"48","author":"AY Joybari","year":"2014","unstructured":"Joybari AY, Sarbaz S, Azadeh P, Mirafsharieh SA, Rahbari A, Farasatinasab M, et al. Oxaliplatin-induced renal tubular vacuolization. Ann Pharmacother. 2014;48:796\u2013800. https:\/\/doi.org\/10.1177\/1060028014526160.","journal-title":"Ann Pharmacother"},{"key":"3116_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","volume":"60","author":"J Rossert","year":"2001","unstructured":"Rossert J. Drug-induced acute interstitial nephritis. Kidney Int. 2001;60:804\u201317.","journal-title":"Kidney Int"},{"key":"3116_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81:442\u20138.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03116-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03116-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03116-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T12:04:21Z","timestamp":1680005061000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03116-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03116-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case and accompanying data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competeing interests"}}],"article-number":"76"}}